Literature DB >> 15616100

Successful management of tachycardiac atrial fibrillation in a septic patient with landiolol.

Yuko Yoshida, Takashi Hongo, Atsuhiro Sakamoto, Ryo Ogawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15616100     DOI： 10.1213/01.ANE.0000140814.28118.6F

Source DB:  PubMed          Journal:  Anesth Analg        ISSN： 0003-2999            Impact factor:   5.108


× No keyword cloud information.
  10 in total

1.  Age and sex-related differences in dose-dependent hemodynamic response to landiolol hydrochloride during general anesthesia.

Authors:  Ju Mizuno; Ikuto Yoshiya; Takeshi Yokoyama; Yoshitsugu Yamada; Hideko Arita; Kazuo Hanaoka
Journal:  Eur J Clin Pharmacol       Date:  2007-01-09       Impact factor: 2.953

2.  Impact of patient characteristics on the efficacy and safety of landiolol in patients with sepsis-related tachyarrhythmia: Subanalysis of the J-Land 3S randomised controlled study.

Authors:  Naoyuki Matsuda; Osamu Nishida; Takumi Taniguchi; Masaki Okajima; Hiroshi Morimatsu; Hiroshi Ogura; Yoshitsugu Yamada; Tetsuji Nagano; Akira Ichikawa; Yasuyuki Kakihana
Journal:  EClinicalMedicine       Date:  2020-10-13

3.  Acute rate control in atrial fibrillation: an urgent need for the clinician.

Authors:  Gheorghe-Andrei Dan; Anca R Dan; Andreea Ivanescu; Adrian C Buzea
Journal:  Eur Heart J Suppl       Date:  2022-06-13       Impact factor: 1.624

4.  Landiolol hydrochloride for early postoperative tachycardia after transthoracic esophagectomy.

Authors:  Kazuhiko Mori; Kazuhiko Yamada; Takashi Fukuda; Takashi Mitsui; Takayuki Kitamura; Daisuke Yamaguchi; Jiro Ando; Ikuo Wada; Sachiyo Nomura; Nobuyuki Shimizu; Yasuyuki Seto
Journal:  Surg Today       Date:  2013-05-15       Impact factor: 2.549

5.  Clinical role and efficacy of landiolol in the intensive care unit.

Authors:  Yuko Yoshida; Katsuyuki Terajima; Chiyo Sato; Shinji Akada; Yasuo Miyagi; Takashi Hongo; Shinhiro Takeda; Keiji Tanaka; Atsuhiro Sakamoto
Journal:  J Anesth       Date:  2008-02-27       Impact factor: 2.078

6.  High concentrations of landiolol, a beta(1)-adrenoceptor antagonist, stimulate smooth muscle contraction of the rat trachea through the Rho-kinase pathway.

Authors:  Osamu Shibata; Kenji Nishioka; Masakazu Yamaguchi; Tetsuji Makita; Koji Sumikawa
Journal:  J Anesth       Date:  2008-02-27       Impact factor: 2.078

7.  A low-dose β1-blocker in combination with milrinone improves intracellular Ca2+ handling in failing cardiomyocytes by inhibition of milrinone-induced diastolic Ca2+ leakage from the sarcoplasmic reticulum.

Authors:  Shigeki Kobayashi; Takehisa Susa; Hironori Ishiguchi; Takeki Myoren; Wakako Murakami; Takayoshi Kato; Masakazu Fukuda; Akihiro Hino; Takeshi Suetomi; Makoto Ono; Hitoshi Uchinoumi; Hiroki Tateishi; Mamoru Mochizuki; Tetsuro Oda; Shinichi Okuda; Masahiro Doi; Takeshi Yamamoto; Masafumi Yano
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

8.  Study into the reversal of septic shock with landiolol (beta blockade): STRESS-L Study protocol for a randomised trial.

Authors:  Ranjit Lall; Dipesh Mistry; Emma Skilton; Nafisa Boota; Scott Regan; Julian Bion; Simon Gates; Anthony C Gordon; Janet Lord; Daniel Francis McAuley; Gavin Perkins; Mervyn Singer; Duncan Young; Tony Whitehouse
Journal:  BMJ Open       Date:  2021-02-16       Impact factor: 2.692

9.  Landiolol for managing atrial fibrillation in intensive care.

Authors:  Sebastian Rehberg; Michael Joannidis; Tony Whitehouse; Andrea Morelli
Journal:  Eur Heart J Suppl       Date:  2018-01-08       Impact factor: 1.803

Review 10.  Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature.

Authors:  Yujiro Matsuishi; Bryan J Mathis; Nobutake Shimojo; Satoru Kawano; Yoshiaki Inoue
Journal:  Vasc Health Risk Manag       Date:  2020-04-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.